We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$5.58B
AUM Growth
+$184M
Cap. Flow
-$168M
Cap. Flow %
-3.01%
Top 10 Hldgs %
14.71%
Holding
368
New
29
Increased
65
Reduced
177
Closed
32

Top Buys

Rank Stock Value
1
TWLO icon
Twilio
TWLO
+$35.3M
2
ETSY icon
Etsy
ETSY
+$34.9M
3
JRVR icon
James River Group Holdings
JRVR
+$22.4M
4
SFM icon
Sprouts Farmers Market
SFM
+$18.9M
5
TDOC icon
Teladoc Health
TDOC
+$18.8M

Top Sells

Rank Stock Value
1
SPLK
Splunk Inc
SPLK
+$39.1M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$36.3M
3
TYL icon
Tyler Technologies
TYL
+$29.3M
4
NUAN
Nuance Communications, Inc.
NUAN
+$26.6M
5
WBS icon
Webster Financial
WBS
+$23.4M

Sector Composition

Rank Sector Weight
1 Technology 20.82%
2 Healthcare 17.63%
3 Financials 14.42%
4 Consumer Discretionary 12.71%
5 Industrials 11.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANDE icon
251
Andersons Inc
ANDE
$2.19B
$7.65M 0.14%
250,507
-25,582
-9% -$772K
FOLD
252
DELISTED
Amicus Therapeutics
FOLD
$6.95M 0.12%
720,586
+30,799
+4% +$301K
TBPH icon
253
Theravance Biopharma
TBPH
$877M
$6.67M 0.12%
459,716
-24,490
-5% -$460K
IONS icon
254
Ionis Pharmaceuticals
IONS
$9.32B
$6.48M 0.12%
162,528
-9,820
-6% -$385K
IOVA icon
255
Iovance Biotherapeutics
IOVA
$2.89B
$6.42M 0.12%
246,582
+10,398
+4% +$270K
IMVT icon
256
Immunovant
IMVT
$8.35B
$3.08M 0.06%
291,456
-15,547
-5% -$217K
ACHL
257
DELISTED
Achilles Therapeutics
ACHL
$2.21M 0.04%
225,669
-96,592
-30% -$1.31M
ZBRA icon
258
Zebra Technologies
ZBRA
$18.1B
$2.14M 0.04%
4,034
– –
MANH icon
259
Manhattan Associates
MANH
$11.5B
$1.88M 0.03%
13,007
-2,490
-16% -$332K
ADSK icon
260
Autodesk
ADSK
$53.2B
$1.85M 0.03%
6,355
– –
KSU
261
DELISTED
Kansas City Southern
KSU
$1.83M 0.03%
6,443
-73
-1% -$21.1K
CGNX icon
262
Cognex
CGNX
$10.7B
$1.78M 0.03%
21,162
– –
SI
263
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$1.72M 0.03%
21,631
– –
WST icon
264
West Pharmaceutical
WST
$24.8B
$1.68M 0.03%
4,689
– –
PNFP icon
265
Pinnacle Financial Partners Inc
PNFP
$16.1B
$1.67M 0.03%
18,901
– –
TSCO icon
266
Tractor Supply
TSCO
$18.5B
$1.64M 0.03%
43,955
– –
DHR icon
267
Danaher
DHR
$146B
$1.63M 0.03%
6,838
– –
DAR icon
268
Darling Ingredients
DAR
$9.93B
$1.6M 0.03%
23,721
-4,500
-16% -$317K
ANSS
269
DELISTED
Ansys
ANSS
$1.59M 0.03%
4,597
– –
TECH icon
270
Bio-Techne
TECH
$11.2B
$1.58M 0.03%
14,076
– –
CTLT
271
DELISTED
CATALENT, INC.
CTLT
$1.47M 0.03%
13,584
– –
MTZ icon
272
MasTec
MTZ
$22B
$1.46M 0.03%
13,740
-2,330
-14% -$253K
BG icon
273
Bunge Global
BG
$21.5B
$1.44M 0.03%
18,400
– –
ROK icon
274
Rockwell Automation
ROK
$49.6B
$1.44M 0.03%
5,024
– –
NOVT icon
275
Novanta
NOVT
$6.27B
$1.37M 0.02%
10,181
– –
9 10
11
12 13

Similar funds

CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
EP
Edgestream Partners Princeton, New Jersey $3.05B AUM 12.73% 1-Year Est. Return

Peregrine Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Peregrine Capital Management held 368 positions worth $5.58B, up 3.4% from $5.39B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Peregrine Capital Management withdrew a net $168M in Q2 2021, closing 32 positions and reducing 177 holdings. Its most notable exit was Splunk Inc, an estimated $39.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Peregrine Capital Management opened a new position in Twilio worth $40.1M.

  • Peregrine Capital Management's largest Q2 2021 buy was Twilio: 101,821 shares worth $40.1M.
  • Peregrine Capital Management added most to Teladoc Health in Q2 2021, an estimated $18.8M increase.
  • Peregrine Capital Management's biggest Q2 2021 reduction was Webster Financial, cutting an estimated $23.4M.
  • Peregrine Capital Management fully exited Splunk Inc in Q2 2021, selling an estimated $39.1M.
  • Peregrine Capital Management's ten largest holdings make up 15% of its $5.58B portfolio in Q2 2021.
  • Peregrine Capital Management opened 29 new positions and closed 32 in Q2 2021.
  • Peregrine Capital Management's portfolio value rose 3.4% quarter-over-quarter to $5.58B.

Based on Peregrine Capital Management's 13F filing for Q2 2021, filed 3 Aug 2021.